In addition, Toghill BJ et al. demonstrated gene-specific alterations in DNA methylation within VSMCs derived from AAA patients, identifying significant associations between CpG methylation in the SMYD2 promoter and reduced SMYD2 expression, thereby indicating the presence of aberrant DNA methylation in AAA-related VSMCs [185]. Here, SMYD2 is linked to triple-A syndrome.